Clinical trial completion rates decline during COVID-19 pandemic

Social distancing and lockdowns may have affected clinical researchers' ability to finish trials, researchers report. Study completion rates dropped worldwide between 13 percent and 23 percent, depending on the type of research sponsor and geographic location, between April and October 2020.